🌟 Employee Spotlight 🌟 - We're excited to shine a light on Terrence Walters, one of our outstanding team members at ADMA Biologics! Terrence has been a dedicated member of our team for 3 years, bringing expertise, passion, and unwavering commitment to his role. His contributions have been instrumental in driving our mission to provide essential therapies to patients in need. His innovative thinking and collaborative spirit make him a valued team player and a joy to work with. Thank you, Terrence, for your hard work and dedication. You exemplify the core values of ADMA Biologics, and we're proud to have you on our team! #EmployeeSpotlight #ADMABiologics #TeamExcellence #HealthcareHeroes #InnovationInHealthcare #IVIG
About us
ADMA Biologics is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. ADMA currently manufactures and markets three United States Food and Drug Administration (FDA) approved plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases: BIVIGAM® (immune globulin intravenous, human) for the treatment of primary humoral immunodeficiency (PI); ASCENIV™ (immune globulin intravenous, human – slra 10% liquid) for the treatment of PI; and NABI-HB® (hepatitis B immune globulin, human) to provide enhanced immunity against the hepatitis B virus. ADMA manufactures its immune globulin products at its FDA-licensed plasma fractionation and purification facility located in Boca Raton, Florida. Through its ADMA BioCenters subsidiary, ADMA also operates as an FDA-approved source plasma collector in the U.S., which provides a portion of its blood plasma for the manufacture of its products. ADMA’s mission is to manufacture, market and develop specialty plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases and management of immune compromised patient populations who suffer from an underlying immune deficiency, or who may be immune compromised for other medical reasons. ADMA has received U.S. Patents: 9,107,906, 9,714,283, 9,815,886, 9,969,793 and 10,259,865 related to certain aspects of its products and product candidates. For more information, please visit www.admabiologics.com.
- Website
-
http://www.admabiologics.com
External link for ADMA Biologics, Inc.
- Industry
- Biotechnology Research
- Company size
- 501-1,000 employees
- Headquarters
- Ramsey, NJ
- Type
- Public Company
- Founded
- 2004
- Specialties
- Plasma Collection, Plasma Products, Pharmaceutical Manufacturing, Biologics, Biotechnology, Immune Deficiency, and Infectious Disease
Locations
-
Primary
465 Route 17 South
Ramsey, NJ 07446, US
-
5800 Park of Commerce Blvd., NW
Boca Raton, FL 33487, US
-
166 Ernest W. Barrett Parkway, NE
Kennesaw, GA 30066, US
Employees at ADMA Biologics, Inc.
Updates
-
Register to watch Elena Perez, MD and Nicholas Hartog, MD discuss “Clinical expert insights into challenges and management of respiratory infections in patients with primary immunodeficiency” bit.ly/faais2024 #FAAIS2024 #ADMA
-
Celebrating Independence Day with ADMA Biologics! As we commemorate the 4th of July, we honor the spirit of freedom and innovation that drives our nation forward. At ADMA Biologics, we are proud to contribute to the health and well-being of our communities by advancing immunoglobulin therapies and plasma-derived products. Let’s remember the sacrifices made for our independence and strive to make a difference every day. Wishing everyone a safe and happy Independence Day! #ADMAstrong #4thofJuly
-
🌟 Employee Spotlight: Meet Leibeth Morilla, our shining star at ADMA Biologics! Leibeth's dedication, expertise, and passion have truly elevated our team's success in delivering life-saving biologics. Join us in celebrating her outstanding contributions to our mission of advancing patient care! #ADMA #EmployeeSpotlight #BiotechExcellence
-
Honored to have participated and join as a sponsor at the Immune Deficiency Foundation 2024 PI Conference this weekend in Chicago. It was a privilege to meet and be inspired by patients and loved ones living with #primaryimmunodeficiency who embody courage and empathy in the face of a devastating rare disease. Thank you to the Immune Deficiency Foundation for their unwavering and ongoing commitment to advocating for patients, and to the clinicians and researchers who advance innovation and science. We proudly stand by the #primaryimmunodeficiency community and continue with inspiration toward our mission, because patients are counting on us. #DonatePlasma
-
Honoring and remembering the brave men and women who made the ultimate sacrifice for our country this Memorial Day. At ADMA Biologics, we express our deepest gratitude to those who served and their families. Their courage and sacrifice will never be forgotten. #MemorialDay #RememberAndHonor #ADMAtributes
-
Happy National Nurses Week! Join us in recognizing the extraordinary dedication and compassion of nurses everywhere. Your tireless commitment to patient care inspires us daily. Thank you for all you do! 💙 #NationalNursesDay #NursesRock #HealthcareHeroes #ADMA #IVIG
-
Register to watch Jolan Walter MD and Nicholas Hartog MD discuss “Effectively managing recurrent respiratory infections in individuals with primary immunodeficiency in clinical practice” bit.ly/cis24adma #CIS2024 #ADMA
-
Register to watch Dareen D Siri MD discuss “My Clinical Practice: Personalizing IgRT to Manage Recurrent Respiratory Infections in PI” bit.ly/taais2024 #TAAIS2024 #ADMA
-
World PI Week is here, and at ADMA Biologics, we're proud to stand alongside patients, caregivers, and advocates in raising awareness for primary immunodeficiency disorders. Together, let's illuminate the importance of early diagnosis, access to treatment, and ongoing support for those living with PI. Join us in championing a healthier future for all. #WorldPIWeek #ADMAcares #ImmunodeficiencyAwareness #IVIG #DonatePlasma #ADMA